Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
meeting entities : Genmab a::S save search
Bavarian Nordic A/S – Notice Convening Annual General Meeting
Published: 2024-03-21 (Crawled : 11:00) - globenewswire.com
GNMSF | $290.38 3.83% 220
|
Health Technology
|
| O: 0.03%
H: 3.03%
C: 1.75%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 0.14%
H: 0.24%
C: 0.24%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.03%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.3%
H: 0.0%
C: 0.0%
NTLA | $21.57 1.17% 1.16% 1.4M
|
Health Technology
|
| O: 2.12%
H: 0.6%
C: -2.54%
GMAB | $28.72 1.38% 1.36% 360K
|
Health Technology
|
| O: 1.19%
H: 0.47%
C: -0.77%
meeting
Passing of Genmab A/S’ Annual General Meeting
Published: 2024-03-13 (Crawled : 15:00) - globenewswire.com
GNMSF | $290.38 3.83% 220
|
Health Technology
|
| O: 3.45%
H: 0.24%
C: -2.87%
GMAB | $28.72 1.38% 1.36% 360K
|
Health Technology
|
| O: 0.92%
H: 0.5%
C: -1.2%
meeting
Notice to Convene the Annual General Meeting of Genmab A/S
Published: 2024-02-15 (Crawled : 11:00) - globenewswire.com
GNMSF | $290.38 3.83% 220
|
Health Technology
|
| O: 7.56%
H: 0.0%
C: -1.94%
GMAB | $28.72 1.38% 1.36% 360K
|
Health Technology
|
| O: 5.33%
H: 0.31%
C: -2.86%
meeting
Genmab to Hold 2023 R&D Update and ASH Data Review Meeting
Published: 2023-12-12 (Crawled : 12:00) - globenewswire.com
GNMSF | $290.38 3.83% 220
|
Health Technology
|
| O: -4.43%
H: 0.76%
C: -0.99%
GMAB | $28.72 1.38% 1.36% 360K
|
Health Technology
|
| O: -5.33%
H: 0.46%
C: 0.13%
review update meeting
Genmab Announces Multiple Abstracts to be Presented at the 65th Annual Meeting and Exposition of the American Society of Hematology (ASH)
Published: 2023-11-02 (Crawled : 13:00) - globenewswire.com
GNMSF | $290.38 3.83% 220
|
Health Technology
|
| O: -0.24%
H: 0.07%
C: -3.37%
GMAB | $28.72 1.38% 1.36% 360K
|
Health Technology
|
| O: 0.14%
H: 0.0%
C: -3.62%
meeting
Genmab Showcases Data From Comprehensive Epcoritamab Development Program in Patients Across B-Cell Lymphomas at European Hematology Association (EHA) Annual Meeting 2023
Published: 2023-06-09 (Crawled : 07:00) - globenewswire.com
GNMSF | $290.38 3.83% 220
|
Health Technology
|
| O: 1.67%
H: 0.0%
C: -3.3%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: -0.06%
H: 1.18%
C: 0.45%
GMAB | $28.72 1.38% 1.36% 360K
|
Health Technology
|
| O: -0.44%
H: 0.18%
C: -0.44%
association lymphomas meeting program
Genmab Announces Multiple Abstracts to be Presented at the American Society of Clinical Oncology (ASCO) Annual Meeting and European Hematology Association (EHA) Congress
Published: 2023-05-25 (Crawled : 21:00) - globenewswire.com
GNMSF | $290.38 3.83% 220
|
Health Technology
|
| O: -0.34%
H: 0.54%
C: -0.67%
GMAB | $28.72 1.38% 1.36% 360K
|
Health Technology
|
| O: -0.17%
H: 0.82%
C: 0.4%
association meeting
Passing of Genmab A/S’ Annual General Meeting
Published: 2023-03-29 (Crawled : 14:00) - globenewswire.com
GNMSF | $290.38 3.83% 220
|
Health Technology
|
| O: 0.76%
H: 0.65%
C: 0.38%
GMAB | $28.72 1.38% 1.36% 360K
|
Health Technology
|
| O: 0.73%
H: 0.8%
C: 0.48%
meeting
Bavarian Nordic A/S – Notice Convening Annual General Meeting
Published: 2023-03-07 (Crawled : 14:00) - globenewswire.com
GRNA | $0.2995 -0.03% -0.07% 0
|
Professional, Scientific, and T...
|
| O: 3.93%
H: 6.0%
C: -0.42%
GNMSF | $290.38 3.83% 220
|
Health Technology
|
| O: -3.32%
H: 3.52%
C: 0.25%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.34%
H: 0.1%
C: -1.28%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.65%
H: 0.0%
C: 0.0%
NTLA | $21.57 1.17% 1.16% 1.4M
|
Health Technology
|
| O: -0.2%
H: 3.85%
C: 0.06%
GMAB | $28.72 1.38% 1.36% 360K
|
Health Technology
|
| O: -0.58%
H: 0.25%
C: -1.3%
meeting
Notice to Convene the Annual General Meeting of Genmab A/S
Published: 2023-02-23 (Crawled : 15:00) - globenewswire.com
GNMSF | $290.38 3.83% 220
|
Health Technology
|
| O: -1.93%
H: 0.83%
C: -1.87%
GMAB | $28.72 1.38% 1.36% 360K
|
Health Technology
|
| O: -1.5%
H: 1.35%
C: -0.08%
meeting
Genmab Showcases Data From Robust Development Program Evaluating Epcoritamab (DuoBody®-CD3xCD20) in Patients Across a Broad Range of B-Cell Lymphomas at the 64th Annual ASH Meeting
Published: 2022-12-11 (Crawled : 00:00) - globenewswire.com
GNMSF | $290.38 3.83% 220
|
Health Technology
|
| O: 1.4%
H: 2.59%
C: -1.22%
GMAB | $28.72 1.38% 1.36% 360K
|
Health Technology
|
| O: 0.09%
H: 3.47%
C: 2.83%
cd20 duobody lymphomas meeting program
ADC Therapeutics Announces Abstracts Accepted for Presentation at the 64th ASH Annual Meeting
Published: 2022-11-03 (Crawled : 14:00) - biospace.com/
GNMSF | $290.38 3.83% 220
|
Health Technology
|
| O: -2.44%
H: 5.65%
C: 5.65%
ADCT | $4.72 -0.84% 0.0% 320K
|
Health Technology
|
| O: -2.18%
H: 8.91%
C: 8.17%
GMAB | $28.72 1.38% 1.36% 360K
|
Health Technology
|
| O: -1.73%
H: 4.51%
C: 3.15%
meeting therapeutics presentation
Genmab Announces Multiple Abstracts to be Presented at the 64th Annual Meeting and Exposition of the American Society of Hematology (ASH)
Published: 2022-11-03 (Crawled : 13:00) - globenewswire.com
GNMSF | $290.38 3.83% 220
|
Health Technology
|
| O: -2.44%
H: 5.65%
C: 5.65%
GMAB | $28.72 1.38% 1.36% 360K
|
Health Technology
|
| O: -1.73%
H: 4.51%
C: 3.15%
meeting
Seagen and Genmab Present Data from Tisotumab Vedotin (TIVDAK®) Clinical Development Program and Additional Cervical Cancer Research at ASCO 2022 Annual Meeting
Published: 2022-06-06 (Crawled : 15:20) - biospace.com/
GNMSF | $290.38 3.83% 220
|
Health Technology
|
| O: -0.79%
H: 5.87%
C: 0.32%
SGEN | $228.74 0.1% 20M
|
Health Technology
|
| O: 1.77%
H: 0.72%
C: 0.08%
GMAB | $28.72 1.38% 1.36% 360K
|
Health Technology
|
| O: 0.26%
H: 0.34%
C: -1.81%
tivdak research program asco cancer
Genmab and Seagen Present Data from Tisotumab Vedotin (TIVDAK®) Clinical Development Program and Additional Cervical Cancer Research at ASCO 2022 Annual Meeting
Published: 2022-06-06 (Crawled : 15:20) - globenewswire.com
GNMSF | $290.38 3.83% 220
|
Health Technology
|
| O: -0.79%
H: 5.87%
C: 0.32%
SGEN | $228.74 0.1% 20M
|
Health Technology
|
| O: 1.77%
H: 0.72%
C: 0.08%
GMAB | $28.72 1.38% 1.36% 360K
|
Health Technology
|
| O: 0.26%
H: 0.34%
C: -1.81%
tivdak research program asco cancer
Passing of Genmab A/S’ Annual General Meeting
Published: 2022-03-29 (Crawled : 13:20) - globenewswire.com
GNMSF | $290.38 3.83% 220
|
Health Technology
|
| O: 2.11%
H: 5.31%
C: 5.29%
GMAB | $28.72 1.38% 1.36% 360K
|
Health Technology
|
| O: 0.56%
H: 0.61%
C: -1.63%
Bavarian Nordic A/S – Notice Convening Annual General Meeting
Published: 2022-03-14 (Crawled : 08:00) - globenewswire.com
GNMSF | $290.38 3.83% 220
|
Health Technology
|
| O: 8.05%
H: 1.77%
C: -5.21%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.91%
H: 0.0%
C: 0.0%
OBSV | $0.1018 -15.52% -18.95% 8.2M
|
Health Technology
|
| O: -3.02%
H: 0.0%
C: 0.0%
NTLA | $21.57 1.17% 1.16% 1.4M
|
Health Technology
|
| O: -9.43%
H: 0.0%
C: 0.0%
GMAB | $28.72 1.38% 1.36% 360K
|
Health Technology
|
| O: -0.8%
H: 0.0%
C: 0.0%
BMRN | $88.68 -1.54% -1.57% 1.8M
|
Health Technology
|
| O: -1.03%
H: 0.0%
C: 0.0%
Notice to Convene the Annual General Meeting of Genmab A/S
Published: 2022-02-24 (Crawled : 12:00) - biospace.com/
GNMSF | $290.38 3.83% 220
|
Health Technology
|
| O: -0.93%
H: 5.16%
C: 5.16%
GMAB | $28.72 1.38% 1.36% 360K
|
Health Technology
|
| O: -2.63%
H: 0.0%
C: 0.0%
Genmab Announces Abstracts Evaluating Investigational Solid Tumor Therapies to be Presented at the Society for Immunotherapy of Cancer’s 36th Annual Meeting (SITC 2021)
Published: 2021-10-01 (Crawled : 12:15) - globenewswire.com
GNMSF | $290.38 3.83% 220
|
Health Technology
|
| O: 3.86%
H: 0.57%
C: 0.57%
GMAB | $28.72 1.38% 1.36% 360K
|
Health Technology
|
| O: -1.01%
H: 0.42%
C: -0.23%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: -8.06%
H: 3.28%
C: 1.51%
immunotherapy therapy cancer solid tumors
ADC Therapeutics Announces Presentations at the 2021 ASCO Annual Meeting
Published: 2021-05-19 (Crawled : 00:00) - biospace.com/
ADCT | $4.72 -0.84% 0.0% 320K
|
Health Technology
|
| O: -2.09%
H: 2.14%
C: -1.07%
GMAB | $28.72 1.38% 1.36% 360K
|
Health Technology
|
| O: 0.0%
H: 0.89%
C: 0.77%
presentation therapeutics
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.